7 in 10 Newborns Not Tested for Hearing Loss: Cochlear India Survey

admin
admin
· 4 min read
7 in 10 newborns not tested for hearing loss: Cochlear India survey

Most mothers (84.1%) believed that children should be tested for hearing loss at birth, but few (38.9%) actually had their child screened, found a survey by Cochlear India and First Moms Club. These findings show that while mothers are well aware of the need to detect hearing loss early in childhood, they are not fully aware of what they must do or where they can go to get their children screened. The Cochlear India survey was conducted with First Moms Club in the lead up to World Hearing Day (March 3rd) to find out how much Indian mothers knew about hearing loss in children.

An estimated 5-6 of every 1000 newborns suffer from some degree of hearing loss in India[i], but few parents are able to recognize signs or know how to seek treatment. This delays diagnosis well after the critical period of intervention.

Dr. Milind Kirtane, Senior ENT Consultant and Cochlear Implant Surgeon, PD Hinduja Hospital, Saifee Hospital and SRCC Mumbai, said, “Countries that have made newborn hearing screening mandatory are able to take corrective measures in children as young as 6 months of age. It is very encouraging to see the Kerala government push for universal newborn hearing screening and I sincerely hope the same happens countrywide. This must become our national priority.”

So far, Kerala is the first state in the country to provide hearing screening for children in all government centers. The Kerala Social Security Mission developed a tablet/computer-based data management software where real-time data of newborn screening can be recorded and shared with other institutions such as District Early Intervention Centers (DEICs) and medical colleges. Additionally, measures have been undertaken to ensure follow up and tracking in Anganwadies and schools.

Mr. Brett Lee, the Former Australian Cricketer and Cochlear’s Global Hearing Ambassador, commented, “All too often, we take little things for granted such as how much hearing matters. It was a big wake up call for me when my son was diagnosed with hearing loss at the young age of 5. We were fortunate enough to restore his hearing, but what about the millions of children who suffer from the condition every day? Early screening for hearing loss can ensure that children are diagnosed and treated early, allowing them to grow up into well-adjusted adults.”

Three in 10 mothers surveyed were not sure if children with hearing loss were able to hear again or lead a normal life. The earlier a child is tested, diagnosed and treated for hearing loss, greater the chances of realizing his or her full potential. Research[ii] shows that children identified with hearing loss who get early intervention can develop language (spoken and/or signed) skills on par with their peers with normal hearing. These children are able to attend mainstream schools, communicate with their teachers and classmates, make new friends and feel confident in a world full of sound.

Cochlear is supporting the call for action on hearing loss with its “Hearing Matters” awareness campaign. “Hearing Matters” urges everyone, especially parents, to learn more about hearing loss in children so they know what signs to look out for and determine if their child may need a hearing evaluation. Any parent that is concerned about their child’s hearing should seek the help of a healthcare professional, as there are many opportunities for treatment and care. For more information visit hearingmatters.info/in/

[i] Infant Hearing Screening in India: Current Status and Way Forward- Suneela Garg et al, Int J Prev Med. 2015; 6: 113. Accessible at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689099/

[ii] Effects of Hearing Loss on Development: American Speech – Language- Hearing Association. Accessible at http://www.asha.org/public/hearing/Effects-of-Hearing-Loss-on-Development/

 

Read Next

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya
News
June 5, 2026

Centre Reaffirms Commitment to Building Healthcare Infrastructure Across Northeast India; Nadda Inaugurates Super-Specialty Hospital in Meghalaya

Union Health Minister J P Nadda on Thursday declared that the Central Government remains firmly committed to strengthening healthcare infrastructure across the Northeast and ensuring that advanced medical services reach people living in remote and underserved areas of the region. Nadda made these remarks while inaugurating ARHI Hospital in Meghalaya’s Ri-Bhoi district- a new super-specialty […]
Article by: IMT News Desk
Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today
News
June 5, 2026

Hexagon Nutrition Raises Rs 41.66 Crore from Anchor Investors Ahead of Rs 139-Crore IPO Opening Today

Mumbai-based Hexagon Nutrition Ltd has mobilised Rs 41.66 crore from anchor investors ahead of its initial public offering (IPO), which opened for public subscription on June 5 and will remain open until June 9, 2026. According to a circular uploaded on BSE’s website, the company allotted a total of 92.57 lakh equity shares to anchor […]
Article by: IMT News Desk
Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval
News
June 5, 2026

Otsuka’s Voyxact Shows Kidney Function Preservation in Late-Stage IgAN Trial, Setting Stage for Full FDA Approval

Otsuka Pharmaceutical has reported that its approved kidney disease drug Voyxact (sibeprenlimab) preserved kidney function over 12 months in a late-stage clinical study, marking a significant milestone in the treatment of immunoglobulin A nephropathy (IgAN), a serious autoimmune condition that progressively damages the kidneys. In the Phase 3 VISIONARY trial involving 320 participants, patients who […]
Article by: IMT News Desk
Akums Receives European CEP Approval for Cefpodoxime Proxetil
News
June 4, 2026

Akums Receives European CEP Approval for Cefpodoxime Proxetil

Akums Drugs & Pharmaceuticals Ltd. has received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its active pharmaceutical ingredient (API), Cefpodoxime Proxetil. The CEP certification confirms that Akums’ manufacturing process and quality standards for Cefpodoxime Proxetil comply with the requirements of the European Pharmacopoeia. The […]
Article by: IMT News Desk